Combining metastases-directed SRT with modern biological cancer therapies is associated with a low risk of severe adverse events.

Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...

Mohs microscopic surgery and image-guided superficial radiation therapy (IG-SRT) demonstrate high cure rates for non-melanoma ...

In a cohort of 433 patients receiving metastasis-directed stereotactic radiotherapy (SRT) alongside biological cancer therapy, severe adverse events occurred in less than 10% of cases, with 5.3% ...

BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for ...

BOCA RATON, Fla.--(BUSINESS WIRE)-- Sensus Healthcare, Inc. (SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for ...

Differences in incidence and clinicopathologic features of secondary bladder cancer after long-term follow-up of brachytherapy and radical prostatectomy for localized prostate cancer. Evaluation of ...

Strategic Partnership Targets U.S. Market Expansion of Superficial Radiotherapy Systems into Hospital-Based and Freestanding Oncology Centers Led by President and CEO John Vano, ROS brings nearly ...